Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Recruiting · NCT07724756 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of QLC2519 in Pediatric Solid Tumor Participants | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Phase 2 | 2026-07-24 | NCT07724756 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 126 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Children's Hospital | Beijing | China | 1 |